Lantheus Holdings, Inc. (LNTH)
83.94
+1.20
(+1.45%)
USD |
NASDAQ |
Apr 15, 16:00
83.94
0.00 (0.00%)
After-Hours: 20:00
Lantheus Holdings Research and Development Expense (Annual) : 177.31M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Anika Therapeutics, Inc. | 25.77M |
| BioCryst Pharmaceuticals, Inc. | 164.74M |
| Iovance Biotherapeutics, Inc. | 300.27M |
| Plus Therapeutics, Inc. | 8.379M |
| BioStem Technologies, Inc. | 7.086M |